You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: February 20, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200630

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

NDA 200630 describes TADALAFIL, which is a drug marketed by Accord Hlthcare, Ajanta Pharma Ltd, Alembic Pharms Ltd, Amneal Pharms Co, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Ltd, Hetero Labs Ltd Iii, Lupin Ltd, Macleods Pharms Ltd, Mylan, Qilu, Sun Pharm, Sunshine Lake, Teva Pharms Usa, Torrent, Unichem Labs Ltd, Watson Labs Inc, and Zydus Pharms, and is included in twenty-nine NDAs. It is available from thirty-six suppliers. Additional details are available on the TADALAFIL profile page.

The generic ingredient in TADALAFIL is tadalafil. There are twenty-five drug master file entries for this compound. Forty suppliers are listed for this compound. Additional details are available on the tadalafil profile page.
Summary for 200630
Formulation / Manufacturing:see details
Pharmacology for NDA: 200630
Medical Subject Heading (MeSH) Categories for 200630
Suppliers and Packaging for NDA: 200630
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TADALAFIL tadalafil TABLET;ORAL 200630 ANDA Mylan Pharmaceuticals Inc. 0378-6976 0378-6976-91 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-6976-91)
TADALAFIL tadalafil TABLET;ORAL 200630 ANDA Mylan Pharmaceuticals Inc. 0378-6976 0378-6976-93 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-6976-93)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength20MG
Approval Date:Aug 3, 2018TE:AB2RLD:No
Regulatory Exclusivity Expiration:Feb 5, 2019
Regulatory Exclusivity Use:PATENT CHALLENGE

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.